Gallbladder Cancer

• CLINICAL_TRIALS trial_result · 2025-01-23
  Clinical Trial Update: Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device [NA]

  A completed validation trial evaluated removal of EpCAM-positive tumor cells from blood collected during tumor surgery using the Catumaxomab…

• CLINICAL_TRIALS trial_result · 2024-12-27
  Clinical Trial Update: Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab [Phase 1]

  Phase 1 trial evaluating dasatinib to prevent oxaliplatin-induced neuropathy in patients with metastatic gastrointestinal cancers receiving …

• CLINICAL_TRIALS trial_result · 2024-12-13
  Clinical Trial Update: Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms [NA]

  This entry notes the completion of a clinical trial evaluating a comprehensive electronic cancer support system for managing cancer-related …

• CLINICAL_TRIALS trial_result · 2024-11-12
  Clinical Trial Update: Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTC [Phase 3]

  Phase 3 trial comparing neoadjuvant gemcitabine plus cisplatin followed by liver resection versus immediate liver resection (with or without…

• CLINICAL_TRIALS trial_result · 2024-11-06
  Clinical Trial Update: A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP [NA]

  A completed clinical trial evaluated the LMA Gastro dual-channel supraglottic airway device for oxygenation during ERCP procedures.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2024-10-22
  Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers [Phase 3]

  A Phase 3 trial evaluating gemcitabine hydrochloride and cisplatin with or without nab-paclitaxel in newly diagnosed advanced biliary tract …

• CLINICAL_TRIALS trial_result · 2024-10-08
  Clinical Trial Update: Outcomes and Prognostic Factors in Hepatopancreatoduodenectomy

  A completed clinical trial from Seoul National University Hospital analyzes outcomes and prognostic factors for hepatopancreatoduodenectomy …

• CLINICAL_TRIALS trial_result · 2024-08-21
  Clinical Trial Update: A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers [Phase 2]

  Phase 2 study of Zanidatamab (ZW25) in advanced or metastatic HER2-amplified biliary tract cancers completed with results posted.

• CLINICAL_TRIALS trial_result · 2023-11-18
  Clinical Trial Update: Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer [Phase 2]

  Phase 2 clinical trial investigating a combination of hepatic artery infusion chemotherapy (HAIC), surufatinib, and tislelizumab for unresec…

• CLINICAL_TRIALS trial_result · 2023-11-03
  Clinical Trial Update: Pembrolizumab in Biliary Tract Cancer [Phase 2]

  Phase 2 trial update of pembrolizumab in biliary tract cancer has been completed.

• CLINICAL_TRIALS trial_result · 2023-09-15
  Clinical Trial Update: Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC [Phase 2]

  Phase 2 trial evaluating Envafolimab in combination with GEMOX as first-line treatment for advanced gallbladder cancer.

• CLINICAL_TRIALS trial_result · 2023-08-04
  Clinical Trial Update: Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer [Phase 3]

  Phase 3 trial evaluating gemcitabine with or without capecitabine in locally advanced, unresectable, or metastatic biliary cancer was termin…

• CLINICAL_TRIALS trial_result · 2023-06-23
  Clinical Trial Update: HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC [Phase 2]

  A Phase 2 trial evaluating hepatic arterial infusion chemotherapy with oxaliplatin, 5-fluorouracil, and bevacizumab in combination with intr…

• CLINICAL_TRIALS trial_result · 2023-06-15
  Clinical Trial Update: Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery [Phase 2]

  Phase 2 clinical trial evaluating ramucirumab in advanced or metastatic biliary cancers that cannot be removed surgically; results completed…

• CLINICAL_TRIALS trial_result · 2023-04-21
  Clinical Trial Update: Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer [NA]

  Clinical trial update for M5A, a Copper-64 labeled anti-CEA monoclonal antibody used in PET imaging to diagnose CEA-positive cancers; the st…

• CLINICAL_TRIALS trial_result · 2023-04-13
  Clinical Trial Update: Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1) [Phase 3]

  Phase 3 TOPAZ-1 trial results for durvalumab in combination with gemcitabine/cisplatin in first-line biliary tract cancer have been posted.

• CLINICAL_TRIALS trial_result · 2022-11-17
  Clinical Trial Update: Tislelizumab Combined With Lenvatinib and GEMOX Versus Tislelizumab Combined With GEMOX in Conversion Therapy of ICC and GBC. [Phase 2]

  Phase 2 trial comparing tislelizumab plus lenvatinib and GEMOX versus tislelizumab plus GEMOX for conversion therapy in potentially resectab…

• CLINICAL_TRIALS trial_result · 2022-09-22
  Clinical Trial Update: Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer [Phase 2]

  Phase 2 trial updating efficacy/safety of trifluridine/tipiracil plus irinotecan for advanced refractory biliary tract cancer; results poste…

• CLINICAL_TRIALS trial_result · 2022-07-15
  Clinical Trial Update: Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydration [Phase 2]

  Phase 2 trial comparing current hydration regimen for the ABC02 chemotherapy regimen to a shorter hydration approach in gallbladder cancer.

• CLINICAL_TRIALS trial_result · 2022-06-13
  Clinical Trial Update: Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC [Phase 2, Phase 3]

  Phase 2/3 trial evaluating gemcitabine plus cisplatin with or without bintrafusp alfa (M7824) in first-line biliary tract cancer; study term…

• CLINICAL_TRIALS trial_result · 2022-03-22
  Clinical Trial Update: Tisleizumab Combined With Lenvatinib and XELOX Regimen (Oxaliplatin Combined With Capecitabine) in the First-line Treatment of Advanced and Unresectable Biliary Tract Tumors [Phase 2]

  Phase 2 trial evaluating tisleizumab with lenvatinib and XELOX in first-line treatment of advanced unresectable biliary tract tumors.

• CLINICAL_TRIALS trial_result · 2022-01-10
  Clinical Trial Update: M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) [Phase 2]

  Phase 2 trial of M7824 monotherapy in second-line biliary tract cancers (cholangiocarcinoma and gallbladder cancer) has completed with resul…

• CLINICAL_TRIALS trial_result · 2021-12-10
  Clinical Trial Update: A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer [Phase 2]

  Phase 2 clinical trial update for MRG002 in HER2-positive biliary tract cancer (advanced/metastatic, unresectable).

• CLINICAL_TRIALS trial_result · 2021-05-27
  Clinical Trial Update: Programs To Support You During Chemotherapy [NA]

  A completed clinical trial sponsored by Wake Forest University Health Sciences focused on providing support during chemotherapy, with result…

• CLINICAL_TRIALS trial_result · 2021-04-15
  Clinical Trial Update: Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) [Phase 2]

  Phase 2 trial evaluating pembrolizumab in combination with CAPOX for advanced biliary tract cancer has completed with posted results.